Why Is Leap Therapeutics Down 9% In Pre-Market Trading? - Leap Therapeutics (NASDAQ:LPTX)

Leap Therapeutics Inc. (NASDAQ:LPTX) is trading at $0.69 in pre-market, down 9.15% on Tuesday.Check out the current price of LPTX stock here.Winklevoss Capital Leads $58.9 Million Private PlacementThe Cambridge, Massachusetts-based biotechnology company announced $58.88 million in cash commitments for a private investment in public equity offering led by Winklevoss Capital. According to an Oct. 6 press release, the deal involves 95,849,353 common shares or pre-funded warrants, along with warrants to purchas ...